HMTXF
Price:
$0.0573
Market Cap:
$15.81M
Hemostemix Inc., a biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions. The company develops cell therapy products from the patient's own blood, which is a non-invasive source of therapeutic cells. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of critical limb ischemia in Canada and the United States, as well as for the treatment of heart and peripheral arterial diseases. The company is also developing various types of cell products, such as synergetic cell populations and neural cell precursors. Hemostemix Inc. is headquartered in Calgary, Canada.
Industry
Biotechnology
IPO Date
2016-01-07
Stock Exchange
OTC
Ticker
HMTXF
According to Hemostemix Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 20.00M. This represents a change of 26.14% compared to the average of 15.86M of the last 4 quarters.
The mean historical Enterprise Value of Hemostemix Inc. over the last ten years is 16.14M. The current 20.00M Enterprise Value has changed 12.29% with respect to the historical average. Over the past ten years (40 quarters), HMTXF's Enterprise Value was at its highest in in the September 2015 quarter at 46.00M. The Enterprise Value was at its lowest in in the March 2020 quarter at 3.57M.
Average
16.14M
Median
15.24M
Minimum
5.05M
Maximum
38.22M
Discovering the peaks and valleys of Hemostemix Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 345.33%
Maximum Annual Enterprise Value = 38.22M
Minimum Annual Increase = -77.48%
Minimum Annual Enterprise Value = 5.05M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 15.64M | 57.31% |
| 2023 | 9.94M | -40.07% |
| 2022 | 16.59M | 58.66% |
| 2021 | 10.45M | -53.51% |
| 2020 | 22.49M | 345.33% |
| 2019 | 5.05M | -77.48% |
| 2018 | 22.42M | 285.98% |
| 2017 | 5.81M | -60.85% |
| 2016 | 14.84M | -61.19% |
| 2015 | 38.22M | -46.51% |
The current Enterprise Value of Hemostemix Inc. (HMTXF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
14.06M
5-year avg
15.02M
10-year avg
16.14M
Hemostemix Inc.’s Enterprise Value is greater than Nymox Pharmaceutical Corporation (5.60M), greater than Devonian Health Group Inc. (5.00M), greater than HOOKIPA Pharma Inc. (-28576470.00), less than Algorae Pharmaceuticals Limited (21.43M), less than EOM Pharmaceuticals Holdings, Inc. (22.39M), greater than Sirona Biochem Corp. (9.38M), greater than Oxford BioDynamics Plc (6.42M), greater than Inhibitor Therapeutics, Inc. (5.72M), greater than Quest PharmaTech Inc. (7.62M), less than Cell Source, Inc. (27.11M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 5.60M | $5.67M | |
| 5.00M | $10.55M | |
| -28576470.00 | $11.10M | |
| 21.43M | $8.27M | |
| 22.39M | $22.05M | |
| 9.38M | $5.60M | |
| 6.42M | $8.95M | |
| 5.72M | $8.63M | |
| 7.62M | $4.82M | |
| 27.11M | $17.11M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hemostemix Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hemostemix Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Hemostemix Inc.'s Enterprise Value?
What is the highest Enterprise Value for Hemostemix Inc. (HMTXF)?
What is the 3-year average Enterprise Value for Hemostemix Inc. (HMTXF)?
What is the 5-year average Enterprise Value for Hemostemix Inc. (HMTXF)?
How does the current Enterprise Value for Hemostemix Inc. (HMTXF) compare to its historical average?